Tag: prognostic factor

Pulmonary MRI with ultrashort echo time is comparable to pulmonary CT

Men with idiopathic pulmonary fibrosis have increased mortality compared with women

byPaary Balakumarand1 others

January 13, 2026

1. Men with idiopathic pulmonary fibrosis (IPF) have a higher comorbidity burden, worse baseline lung function, and shorter survival, with ...

#VisualAbstract Adding a novel inflammatory marker to a scoring tool better predicted mortality in patients with epidermal necrolysis

byKathleen Lau

December 30, 2021

Combined MRI and NIH stroke scores may predict stroke prognosis

Patients with moderate-severe traumatic brain injury may achieve favourable functional outcomes within 12 months of recovery

byGursharan Sohiand1 others

July 7, 2021

1. More than half of patients who experienced moderate-severe traumatic brain injury (ms-TBI) achieved favourable functional outcomes after 12 months ...

#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate

byKathleen Lau

January 15, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: prognostic factor

Men with idiopathic pulmonary fibrosis have increased mortality compared with women

#VisualAbstract Adding a novel inflammatory marker to a scoring tool better predicted mortality in patients with epidermal necrolysis

Patients with moderate-severe traumatic brain injury may achieve favourable functional outcomes within 12 months of recovery

#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate

2MM+ All Access

Look up any US clinician

Recent Reports

The medical literature, distilled daily.

Membership benefits